Modera Wealth Management LLC Sells 89 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Modera Wealth Management LLC cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,069 shares of the financial services provider’s stock after selling 89 shares during the quarter. Modera Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $802,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Transcend Capital Advisors LLC grew its position in shares of iShares Biotechnology ETF by 0.8% during the fourth quarter. Transcend Capital Advisors LLC now owns 10,958 shares of the financial services provider’s stock valued at $1,449,000 after purchasing an additional 92 shares in the last quarter. Chicago Partners Investment Group LLC grew its position in shares of iShares Biotechnology ETF by 2.5% during the fourth quarter. Chicago Partners Investment Group LLC now owns 3,783 shares of the financial services provider’s stock valued at $510,000 after purchasing an additional 94 shares in the last quarter. WealthCare Investment Partners LLC grew its position in shares of iShares Biotechnology ETF by 0.9% during the fourth quarter. WealthCare Investment Partners LLC now owns 10,348 shares of the financial services provider’s stock valued at $1,375,000 after purchasing an additional 96 shares in the last quarter. Capital Investment Advisors LLC grew its position in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after purchasing an additional 99 shares in the last quarter. Finally, Canton Hathaway LLC grew its position in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Canton Hathaway LLC now owns 9,961 shares of the financial services provider’s stock valued at $1,317,000 after purchasing an additional 100 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 0.1 %

Shares of iShares Biotechnology ETF stock opened at $134.36 on Wednesday. The firm has a market cap of $6.35 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. The business has a 50-day moving average price of $135.92 and a 200-day moving average price of $140.53. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.